Doctor profile · Federal record

Dr. Jay Wang, M.D.

Medical Oncology Physician (CMS: Medical Oncology) · Hematology (Internal Medicine) Physician · Naples, FL

  • NPI 1952509606
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 24 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
8350 Sierra Meadows Blvd Fl 2
Naples, FL 341137328
(239) 732-3140
fax (239) 530-1113
Mailing address
Po Box 102222
Atlanta, GA 303682222

Credentials & registration

NPPES · NUCC
NPI registered
July 2007 — 19 yrs on file
Profile last updated
September 2, 2022
Year of graduation
2002 — 24 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State license (1)
Florida #ME101811
Medicaid
FL #000132600

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1952509606. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
427,249
Distinct HCPCS
10
Medicare allowed
$5,714,829
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 129,540 105 $1
J9271 Injection, pembrolizumab, 1 mg 38,200 31 $54
J0897 Injection, denosumab, 1 mg 33,540 226 $23
J1442 Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram 33,120 13 $1
J9025 Injection, azacitidine, 1 mg 28,050 13 $0
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 25,010 72 $8
J0185 Injection, aprepitant, 1 mg 24,050 40 $2
J9299 Injection, nivolumab, 1 mg 21,920 12 $29
J9263 Injection, oxaliplatin, 0.5 mg 14,846 14 $0
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 14,400 11 $47

In context: peer comparison

Among 8 peers in Naples Medical Oncology Physician, average services per provider: 5,004. This provider delivers 85× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$10,970
Transactions
146
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Taiho Oncology, INC. 13 $3,040.26
Takeda Pharmaceuticals U.S.A., INC. 15 $1,896.44
AstraZeneca Pharmaceuticals Lp 22 $1,852.02
Merck Sharp & Dohme LLC 15 $382.63
Pfizer INC. 13 $288.95
Novartis Pharmaceuticals Corporation 13 $255.92
Regeneron Healthcare Solutions, INC. 9 $245.15
Intuitive Surgical, INC. 2 $192.06
Janssen Biotech, INC. 8 $171.48
Celgene Corporation 5 $152.98
Lilly USA, LLC 6 $151.38
E.R. Squibb & Sons, L.L.C. 8 $150.02
BeiGene USA, INC. 6 $139.03
Incyte Corporation 6 $130.91
Eisai INC. 5 $108.28

By nature of payment

Food and Beverage
$5,144
Consulting Fee
$4,763
Travel and Lodging
$1,063

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,573
Patients
518
Total drug cost
$263,919
Drug Type Claims Patients Total cost
Anastrozole Generic 280 90 $10,680
Hydroxyurea Generic 160 47 $8,023
Ondansetron Odt (Ondansetron) Brand 141 81 $4,456
Eliquis (Apixaban) Brand 140 28 $137,948
Xarelto (Rivaroxaban) Brand 106 22 $89,561
Zolpidem Tartrate Generic 94 29 $731
Alprazolam Generic 92 28 $1,154
Levothyroxine Sodium Generic 80 27 $1,421
Oxycodone Hcl Generic 76 16 $2,178
Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) Brand 73 23 $2,776

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Jay Wang's medical specialty?
Dr. Jay Wang practices Medical Oncology Physician in Naples, FL.
Where does Dr. Jay Wang practice?
Dr. Jay Wang practices at 8350 Sierra Meadows Blvd Fl 2, Naples, FL 341137328. Office phone: 2397323140.
What is Dr. Jay Wang's NPI?
Dr. Jay Wang's National Provider Identifier (NPI) is 1952509606, issued by NPPES.
Does Dr. Jay Wang accept Medicare assignment?
Yes. Dr. Jay Wang accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jay Wang commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.